Understanding HER2-Low mBC
Understanding HER2-low mBC
Winship Cancer Institute - Emory University
Defining and Identifying HER2-Low Breast Cancer
FEATURING
Jane Meisel
- 261 views
- February 23, 2023
- 2
ecancer
Overview of the Management of HER2-Low Breast Cancer Patients
FEATURING
Hope Rugo
- 347 views
- February 27, 2023
- 5
ecancer
2023 Updates on HER2-Low Breast Cancer
FEATURING
Sana Al Sukhun
- 209 views
- February 27, 2023
- 2
Keck School of Medicine of USC
Advances in Treatment of HER2+ BC in 2023
FEATURING
William Gradishar
- 405 views
- February 22, 2023
- 3
Dana-Farber Cancer Institute
Impact of DESTINY-Breast04 Data in HER2-Low Breast Cancer: How to Implement in Clinical Practice
FEATURING
Paolo Tarantino
- 943 views
- February 7, 2023
- 10
SABCS 2022 Conference Coverage
SABCS 2022: Comprehensive Genomic Characterization of HER2-Low Breast Cancer
FEATURING
Paolo Tarantino
- 348 views
- December 13, 2022
- 1
SABCS 2022 Conference Coverage
SABCS 2022: Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
FEATURING
Rani Bansal
- 84 views
- December 13, 2022
ESMO 2022 Conference Coverage
ESMO 2022 on DESTINY-Breast04 Patient-Reported Outcomes: T-DXd vs. TPC in HER2-Low mBC
FEATURING
Naoto Ueno
- 470 views
- October 3, 2022
- 2
Penn Medicine Abramson Cancer Center
The New Paradigm of HER2-Low Breast Cancer
FEATURING
Mary Mahler
- 193 views
- January 12, 2023
- 1